These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 16502015

  • 21. The topoisomerase II alpha gene status in primary breast cancer is a predictive marker of the response to anthracycline-based neoadjuvant chemotherapy.
    Kawachi K, Sasaki T, Murakami A, Ishikawa T, Kito A, Ota I, Shimizu D, Nozawa A, Nagashima Y, Machinami R, Aoki I.
    Pathol Res Pract; 2010 Mar 15; 206(3):156-62. PubMed ID: 20089371
    [Abstract] [Full Text] [Related]

  • 22. Clinical evaluation of developed PCR-based method with hydrolysis probes for TOP2A copy number evaluation in breast cancer samples.
    Zaczek A, Markiewicz A, Jaśkiewicz J, Pieńkowski T, Rhone P, Jassem J, Wełnicka-Jaśkiewicz M.
    Clin Biochem; 2010 Jul 15; 43(10-11):891-8. PubMed ID: 20441774
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Increased topoisomerase IIalpha expression in colorectal cancer is associated with advanced disease and chemotherapeutic resistance via inhibition of apoptosis.
    Coss A, Tosetto M, Fox EJ, Sapetto-Rebow B, Gorman S, Kennedy BN, Lloyd AT, Hyland JM, O'Donoghue DP, Sheahan K, Leahy DT, Mulcahy HE, O'Sullivan JN.
    Cancer Lett; 2009 Apr 18; 276(2):228-38. PubMed ID: 19111388
    [Abstract] [Full Text] [Related]

  • 30. HER-2 and topoisomerase II as predictors of response to chemotherapy.
    Pritchard KI, Messersmith H, Elavathil L, Trudeau M, O'Malley F, Dhesy-Thind B.
    J Clin Oncol; 2008 Feb 10; 26(5):736-44. PubMed ID: 18258981
    [Abstract] [Full Text] [Related]

  • 31. A subset of pancreatic adenocarcinomas demonstrates coamplification of topoisomerase IIalpha and HER2/neu: use of immunolabeling and multicolor FISH for potential patient screening andtreatment.
    Hansel DE, Ashfaq R, Rahman A, Wanzer D, Yeo CJ, Wilentz RE, Maitra A.
    Am J Clin Pathol; 2005 Jan 10; 123(1):28-35. PubMed ID: 15762277
    [Abstract] [Full Text] [Related]

  • 32. Dual-colour CISH is a reliable alternative to FISH for assessment of topoisomerase 2-alpha amplification in breast carcinomas.
    García-Caballero T, Prieto O, Vázquez-Boquete A, Gude F, Viaño P, Otero M, Curiel T, Fernández-Rodríguez B, Parrado C, Fraga M, Antúnez JR.
    Breast Cancer Res Treat; 2014 Jan 10; 143(1):81-9. PubMed ID: 24292870
    [Abstract] [Full Text] [Related]

  • 33. New understanding of the role of anthracyclines in early-stage breast cancer: patient selection considerations.
    Gennari A, Pronzato P.
    Clin Breast Cancer; 2008 Dec 10; 8 Suppl 4():S179-83. PubMed ID: 19158039
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Topoisomerase II-alfa gene as a predictive marker of response to anthracyclines in breast cancer.
    Almeida D, Gerhard R, Leitão D, Davilla C, Damasceno M, Schmitt F.
    Pathol Res Pract; 2014 Oct 10; 210(10):675-9. PubMed ID: 25042383
    [Abstract] [Full Text] [Related]

  • 37. Alteration of topoisomerase II-alpha gene in human breast cancer: association with responsiveness to anthracycline-based chemotherapy.
    Press MF, Sauter G, Buyse M, Bernstein L, Guzman R, Santiago A, Villalobos IE, Eiermann W, Pienkowski T, Martin M, Robert N, Crown J, Bee V, Taupin H, Flom KJ, Tabah-Fisch I, Pauletti G, Lindsay MA, Riva A, Slamon DJ.
    J Clin Oncol; 2011 Mar 01; 29(7):859-67. PubMed ID: 21189395
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.